BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai J, Osikowicz M, Sebastiani G. Clinical significance of elevated liver transaminases in HIV-infected patients. AIDS 2019;33:1267-82. [PMID: 31008799 DOI: 10.1097/QAD.0000000000002233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Wekesa C, Parkes-Ratanshi R, Kirk GD, Ocama P. Liver Injury Patterns and Hepatic Toxicity among People Living with and without HIV and Attending Care in Urban Uganda. Int J Hepatol 2023;2023:6717854. [PMID: 36748010 DOI: 10.1155/2023/6717854] [Reference Citation Analysis]
2 Sebastiani G, Milic J, Cervo A, Saeed S, Krahn T, Kablawi D, Al Hinai AS, Lebouché B, Wong P, Deschenes M, Gioè C, Cascio A, Mazzola G, Guaraldi G. Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients. JPM 2022;12:282. [DOI: 10.3390/jpm12020282] [Reference Citation Analysis]
3 Jespersen NA, Axelsen F, Dollerup J, Nørgaard M, Larsen CS. The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era. HIV Med 2021;22:478-90. [PMID: 33645000 DOI: 10.1111/hiv.13077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
4 Klus J, Ly VT, Chan C, Le T. Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort. Med Mycol 2021;59:392-9. [PMID: 33644813 DOI: 10.1093/mmy/myab005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Wood S, Won SH, Hsieh HC, Lalani T, Kronmann K, Maves RC, Utz G, Schofield C, Colombo RE, Okulicz JF, Blaylock J, Agan BK, Ganesan A. Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era. Open Forum Infect Dis 2021;8:ofab076. [PMID: 33738323 DOI: 10.1093/ofid/ofab076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Gruevska A, Moragrega ÁB, Cossarizza A, Esplugues JV, Blas-García A, Apostolova N. Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment. Cells 2021;10:410. [PMID: 33669403 DOI: 10.3390/cells10020410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Henry SR, Hien YE, Sanou SG, Kima A, Ilboudo PD, Kabre E, Traore Y. Evolution of Biochemical, Hematological, Inflammatory and Immunological Markers among Person Living with HIV-1 on ART in Burkina Faso. AID 2021;11:104-121. [DOI: 10.4236/aid.2021.112012] [Reference Citation Analysis]
8 León-torres CA, Rodríguez-salvatierra AD, Bardales-cahua MA, Rodríguez-plasencia CC, Martin-alva EA, Bardales-vásquez CB. Liver Profile in Peruvian Athletes. The FASEB Journal 2020;34:1-1. [DOI: 10.1096/fasebj.2020.34.s1.08914] [Reference Citation Analysis]
9 Sebastiani G, Saeed S, Lebouche B, de Pokomandy A, Szabo J, Haraoui LP, Routy JP, Wong P, Deschenes M, Ghali P, Klein M; LIVEHIV Study Group. Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients. AIDS 2020;34:237-44. [PMID: 31651429 DOI: 10.1097/QAD.0000000000002412] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]